![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 42, 39070-39073, October 18, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§,
,
,
,
From the
Department of Bioresources Science,
Kochi University, Nankoku, Kochi 783-8502 and ¶ Department of
Biotechnology, Kansai University, Suita, Osaka 564-8680, Japan
Received for publication, April 29, 2002, and in revised form, August 21, 2002
| |
ABSTRACT |
|---|
|
|
|---|
Almost all bacteria possess glutamate racemase to
synthesize D-glutamate as an essential component of
peptidoglycans in the cell walls. The enforced production of
glutamate racemase, however, resulted in suppression of cell
proliferation. In the Escherichia coli JM109/pGR3 clone,
the overproducer of glutamate racemase, the copy number
(i.e. replication efficiency) of plasmid DNA declined dramatically, whereas the E. coli WM335 mutant that is
defective in the gene of glutamate racemase showed little genetic
competency. The comparatively low and high activities for DNA
supercoiling were contained in the E. coli JM109/pGR3 and
WM335 cells, respectively. Furthermore, we found that the DNA gyrase of
E. coli was modulated by the glutamate racemase of E. coli in the presence of
UDP-N-acetylmuramyl-L-alanine, which is a
peptidoglycan precursor and functions as an absolute activator for the
racemase. This is the first finding of the enzyme protein participating
in both D-amino acid metabolism and DNA processing.
Bacterial cell walls contain D-amino acids as
essential components of peptidoglycans (alternatively, mureins).
D-Glutamate is introduced into peptidoglycan through its
addition to UDP-N-acetylmuramyl-L-alanine (UDP-MurNAc-L-Ala),1
a peptidoglycan precursor, by
UDP-MurNAc-L-Ala:D-glutamate ligase (EC
6.3.2.9). Glutamate racemase (EC 5.1.1.3) catalyzes the racemization of
glutamate (1). The genes encoding glutamate racemase are ubiquitously
inherited in bacteria, and the Escherichia coli WM335
mutant, in which the enzyme gene was disrupted, required D-glutamate for growth (2). These findings indicate that
glutamate racemase provides D-glutamate for peptidoglycan
synthesis. Glutamate racemase and its gene hereafter are designated
MurI and murI, respectively.
The activity of glutamate racemase, however, usually cannot be
detected in the cells of bacteria, except in a part of lactobacilli and
bacilli (3). Doublet et al. (4) showed that MurI of E. coli catalyzed the glutamate racemization only in the presence of
UDP-MurNAc-L-Ala and concluded that this peptidoglycan
precursor is an absolute activator of the MurI enzyme. On the other
hand, the fact that no ribosome-binding sequence is found upstream of the open reading frames in the murI genes of various
bacteria and the initial codon of the open reading frames often
includes the substitution of the usual ATG for the unusual TTG or GTG
(5, 6) suggests that the murI gene is translated on a
specific mechanism that is still unidentified. It is generally assumed that MurI is strictly controlled so as to operate only during peptidoglycan synthesis (eventually during cell division). In E. coli clones, the enforced production of MurIs resulted in
characteristic changes, such as aberration in nucleoid separation (7)
and suppression of cell proliferation (6, 7), indicating that the
attenuation of murI gene expression and the regulation of MurI production are physiologically significant. In the absence of
D-glutamate, the cells of the E. coli WM335
mutant formed filament elongates (2), as did the mutants defective in
the genes involved in cell division. These observations imply that MurI
plays a role in cell homeostasis other than in the
D-glutamate supply. However, there have been surprisingly
few examples focusing on the multifunctionality of MurI until now. In
this study, the in vivo and in vitro effects of
MurI on some DNA processing in E. coli were investigated.
Here we report the novel function of glutamate racemase,
i.e. the modulation of DNA gyrase activity.
Materials--
Supercoiled pBR322, calf thymus DNA topoisomerase
I, and isopropyl- Bacteria--
E. coli JM109 was purchased from TaKaRa
Shuzo. E. coli WM335 mutant was a kind gift from Prof. Dr.
W. Messer of the Max Planck Institute for Molecular Genetics.
Vector Plasmids--
Vector plasmids pKK223-3 and pTrc99A, both
of which contain an ampicillin (Amp) resistance gene, were obtained
from Amersham Biosciences, and pACYC184 that carries a
tetracycline (Tet) resistance gene was from Nippon Gene. Both plasmids
pGR2 and pGR3 were constructed according to the strategy described
previously (5) and used for analysis of the function of glutamate
racemase. For the production of E. coli DNA gyrase (GyrAB),
plasmid pGYRA, a pTrc99A having the gyrA gene, and plasmid
pGYRB, a pTrc99A having the gyrB gene, were designed by the
method of Mizuuchi et al. (10). To obtain E. coli
DNA toposiomerase IV (ParCE), plasmid pPARC, a pTrc99A having the
perC gene, and plasmid pPARE, a pTrc99A having the parE gene, were prepared by the method of Kato et
al. (11).
Transformation--
E. coli cells were transformed
with the vector plasmid DNA by the CaCl2 method (12) or the
TSS method (13) and grown on the LB media containing appropriate
antibiotics (1, 12).
Measurement of Plasmid Copy Number--
Plasmid copy numbers
were determined densitometrically with a Digital Science EDAS 120 LE
system (Invitrogen) by the method of Projan et al. (14).
Enzyme Assays--
Glutamate racemase was assayed by the method
described previously (3). One unit of MurI was defined as the amount of
enzyme that catalyzed the formation of 1 µmol of
L-glutamate per min.
DNA gyrase was assayed as follows. The reaction mixture (20 µl)
comprised 2 µmol of Tris-HCl (pH 8.0), 1.4 µmol of KCl, 0.2 µmol
of MgCl2, 0.1 µmol of ATP, 0.1 µmol of spermidine
hydrochloride, 0.1 µmol of dithiothreitol, 2 nmol of EDTA, 0.2 mg of
glycerol, 0.5 µg of relaxed pBR322, and enzyme. The enzyme was
replaced with water in a blank. The reaction was essentially performed at 37 °C for 1 h and terminated by the phenol-chloroform
extraction (12). The reaction mixture was electrophoresed in 1% (w/v)
agarose gel (14 × 14 cm) submerged in TPE buffer (90 mM Tris-phosphate, 2 mM EDTA, pH 8.0) at 4 V/cm
at 25 °C for 2.5 h. Gel was stained with ethidium bromide (1 µg/ml). The activity was estimated from both an increase in the
density of bands corresponding to the supercoiled DNA thus formed (10)
and a decrease in that of the relaxed DNA substrate, which were
quantitated with the Digital Science EDAS 120 LE system. One unit of
GyrAB was defined as the amount of enzyme that converted one-half of
relaxed pBR322 into the supercoils per 30 min.
DNA topoisomerases I (TopA) and IV (ParCE) were assayed in the absence
(15) and the presence of ATP (11), respectively. One unit of both
topoisomerases was defined as the amount of enzyme required to fully
relax 0.5 µg of supercoiled pBR322 per h.
Enzymes--
E. coli MurI was purified by the method
described previously (1). The specific activity was 9.6 units
mg
Since overproduction of DNA gyrase into an active form, i.e.
a GyrA2B2 heterotetramer (molecular mass,
373,767 Da), results in strong inhibition of cell growth in bacteria,
E. coli GyrAB was prepared by reconstitution of the A
subunit (GyrA, 96,975 Da) and the B subunit (GyrB, 89,893 Da) (10).
Cell lyses with lysozyme and Brij-58, removal of the DNA extracted with
streptomycin, and precipitation of proteins with ammonium sulfate were
conducted according to the method of Nakanishi et al. (9).
The GyrA preparation from E. coli JM109/pGYRA cells (110 mg
of protein) was applied to a Bio-Rad Bio-Logic FPLC system equipped
with a Bio-Scale DEAE anion-exchange column (volume, 20 ml; Bio-Rad)
(3); the fraction eluted with 0.4 M NaCl contained only the
GyrA protein. The GyrB preparation from E. coli JM109/pGYRB
cells (88 mg of protein) was subjected to affinity chromatography on a
novobiocin-Sepharose column (1.5 × 7 cm; volume, 12.5 ml) (9);
the fraction eluted with 2 M KCl plus 5 M urea
contained only the GyrB protein. The enzyme was reconstituted by
incubation of the purified GyrA and GyrB at an equimolar ratio at
25 °C for 30 min in the presence of 0.1 mM ATP. The
specific activity was 3.8 × 104 units
mg
E. coli ParCE was purified by the method of Kato et
al. (11). The specific activity was 3.3 × 103
units mg Effects on Plasmid Copy Number--
To examine whether the
production of MurI affects DNA processing in E. coli, we
first assayed the plasmid copy numbers in several E. coli
clones. In this experiment, both plasmid pGR2, a pKK223-3 having the
murI gene isolated from the E. coli chromosome, and plasmid pGR3, a pKK223-3 having the designed murI gene
in which a typical ribosome-binding sequence was introduced (5), were
used. The plasmid pKK223-3, the multiplication of which is entirely
dependent on the replication machineries of the host cells,
i.e. the Effects on Genetic Competence--
While examining characteristics
of the E. coli WM335 mutant, we found that its genetic
competence declined dramatically compared with that of E. coli JM109, which has an intact murI gene, and, further, that such a decline in genetic competence of the mutant was
recovered by the complementation of the murI gene with the plasmid pGR2 (Table I). Chandler and
Smith (17) recently reported that, in bacteria, TopA catalyzing the
reverse of the DNA gyrase reaction was essential for the development of
genetic competence. The relationship between the development of the
genetic competence and the intracellular activity for DNA supercoiling
was demonstrated. Our results indicated that MurI affects the
intracellular activity for DNA supercoiling.
Effects on DNA Supercoiling Activities--
The intracellular
activity for DNA supercoiling was practically determined in the balance
of the activities of TopA and GyrAB (18), and net DNA supercoiling
activity of bacterial cells can be determined by using the DNA gyrase
assay system because the cell extracts essentially contain both the
activities of GyrAB, which introduces negative supercoils into DNAs,
and of TopA, which unwinds the supercoiled DNAs. In this study,
comparatively low and high DNA supercoiling activities were observed in
the cells of E. coli JM109/pGR3 and WM335, respectively
(Fig. 2). The supercoiling activity of
E. coli JM109/pGR3 cells was one-tenth that of E. coli JM109/pKK223-3 cells; the intracellular activities of
E. coli WM335 and E. coli WM335/pGR3 were 2-fold
higher and 4-fold less than that of E. coli WM335/pGR2,
respectively. In contrast, there was apparently little difference in
the activities of TopA among the E. coli clones used:
JM109/pKK223-3, 31 ± 7 (units mg Inhibition of DNA Gyrase by Glutamate Racemase--
To clarify if
MurI modulates GyrAB, we followed a change in the apparent activity of
GyrAB in the coexistence of various concentrations of MurI. Bovine
serum albumin, instead of E. coli MurI, was added to the DNA
gyrase assay system as a negative control (Fig.
3, open diamonds). As shown in
Fig. 3A, GyrAB was inhibited by E. coli MurI in
the presence of UDP-MurNAc-L-Ala (closed
circles) but not both enantiomers of glutamate (open
triangles and open squares). Fig. 3A also
reveals that GyrAB probably forms a 1:1 molar stoichiometric inactive
complex with MurI activated by UDP-MurNAc-L-Ala. The
apparent inhibition constant Ki(app) of
MurI against GyrAB was estimated to be 6.8 nM (Fig.
3B) On the other hand, E. coli MurI (0.5 nM) kept the activity of glutamate racemase even in the
presence of a 250-fold molar excess of GyrAB.
Effect of Glutamate Racemase on the Activity of DNA
Topoisomerase IV--
ParCE, a GyrAB paralogue, participates in
the chromosome partitioning (11) that occurs after the DNA replication
in cell division. The enzyme (20 nM), however, remained
active when coexisting with abundant MurI (125 nM). These
suggest that DNA gyrase is the target of glutamate racemase in E. coli.
DNA gyrase (alternatively, bacterial DNA topoisomerase II) is a
pivotal enzyme for various types of DNA processing, including DNA
replication and gene expression, and the strict modulation of the
intracellular activity is indispensable for proper cell division (10).
The first endogenous DNA gyrase modulator, designated as GyrI (9), was
identified from E. coli; it was identical to the SbmC
protein, which had been previously characterized as a member of the DNA
repair system. Because glutamate racemase, however, has been classified
into the group of D-amino acid-metabolic enzymes but not
into that of DNA-processing proteins, such as the GyrI protein, and
does not have any consensus sequences that can be observed in the
DNA-binding motifs (3, 5, 6), the discovery of the novel function of
glutamate racemase as the endogenous inhibitor for DNA gyrase was quite
unexpected. Nevertheless, the existence of such multifunctional
glutamate racemases would be advantageous in the peculiar processes
seen only during bacterial cell division, in which the synthesis of the
peptidoglycan molecules (as an essential constituent of the septum and
cell walls) follows DNA processing (e.g. the decatenation of
daughter DNAs catalyzed by DNA gyrase) (11), for example.
In bacterial glutamate racemases, E. coli MurI
is functionally particular; it is led into an active form by
UDP-MurNAc-L-Ala (4). E. coli MurI thus operates
only during the peptidoglycan synthesis and changes again into an
inactive form with exhaustion of UDP-MurNAc-L-Ala after
peptidoglycan synthesis. As shown in Fig. 3A,
UDP-MurNAc-L-Ala was essential for the inhibition of GyrAB
by E. coli MurI, suggesting that the function of DNA gyrase is suppressed by glutamate racemase at the early stage of the septation
in E. coli cells. It seems likely that this step is important to avoid the appearances of abnormal DNA replication and
decatenation due to excessive DNA gyrase activity. We have identified
the glutamate racemase isozyme of Bacillus subtilis, YrpC
(lately B. subtilis MurI), which was not modulated by
UDP-MurNAc-L-Ala (6). Unlike E. coli MurI,
B. subtilis MurI, whether coexisting with
UDP-MurNAc-L-Ala or not, inhibited DNA
gyrase.2 Although Doublet
et al. (4) previously mentioned a toxicity of
D-glutamate produced by glutamate racemase on the
metabolism and growth of bacterial cells, our observations show that an
active form of glutamate racemase itself but not its reaction product, i.e. D-glutamate, is required for the inhibition
of DNA gyrase, a most crucial enzyme in bacterial cell homeostasis.
Unlike usual amino acid racemases, glutamate racemase contains no
coenzymes such as PLP (3). There is no sequence homology between
glutamate racemase and usual amino acid racemases (6). The catalytic
efficiency of glutamate racemase is exceedingly low compared with those
of PLP-dependent amino acid racemases (5). Interestingly,
the orthologues of glutamate racemase have been found from various
organisms, including peptidoglycan-less organisms such as archaea,
plants, and humans (19). Most of these proteins, however, have not been
characterized yet because of their loss of function as glutamate
racemase. It was recently reported that the glutamate racemase
orthologue-encoding gene was expressed to excess in human carcinoma
(19), in which abnormal DNA replication frequently took place during
cell division. On the other hand, among other PLP-independent amino
acid racemases, the proline racemase from Trypanosoma cruzi
was found to exhibit the function as an immune B-cell mitogen (20).
Some PLP-independent amino acid racemases including glutamate racemase
have possibly evolved from ancient proteins that had not been
originally involved in amino acid metabolism. It remains to be
investigated whether glutamate racemase-like proteins substantially
modulate DNA topoisomerases, as their detailed structural analyses
could provide insights into the molecular evolution of
D-amino acid-metabolic enzymes, deepen the understanding of
the mechanism of cell division, and result in the design of novel pharmaceuticals.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-D-thiogalactopyranoside (IPTG) were
purchased from TaKaRa Shuzo. Relaxed pBR322 was prepared from
supercoiled pBR322 with the DNA topoisomerase I by the method of Ferro
and Olivera (8). UDP-MurNAc-L-Ala was prepared from the
cell extract of E. coli WM335 according to the method
described previously (6). A novobiocin-Sepharose resin was prepared by
the method of Nakanishi et al. (9). All other chemicals were
of analytical grade.
1. Protein concentrations were determined
spectrophotometrically using its theoretical molar extinction
(
278 = 22,280 M
1
cm
1) (1, 4).
1. Protein concentrations were determined using its
theoretical molar extinction (
278 = 248,200 M
1 cm
1) (10).
1. Protein concentrations were determined using
its theoretical molar extinction (
278 = 229,920 M
1 cm
1) (11).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
mechanism (16), was used as a control (usually over
20 copies). As shown in Fig. 1, the
enforced production of MurI by the use of the plasmid pGR3 resulted in
a dramatic decrease in the copy numbers in both E. coli
JM109 and WM335 clone cells (one to several copies). The result also
showed that a decreased plasmid copy number in the E. coli
WM335 mutant was restored by complementation of the native
murI gene with the plasmid pGR2. A decline in negative
superhelicity of the plasmid in the MurI overproducer, E. coli JM109/pGR3, but not of those in E. coli JM109/pKK223-3 and JM109/pGR2 was observed by the use of
chloroquine (data not shown), and this was consistent with what
Balikó and Venetianer (7) had proposed. It thus seems likely that
the replication of ColE1-type plasmids such as pKK223-3 is difficult to
complete properly in E. coli cells exhibiting aberration of the production of MurI due to deficiency in the controls of DNA superhelical density (11). MurI would also influence the replication of
chromosome, since the overexpression and disruption of the murI gene allowed the appearance of abnormal cell growth
in E. coli (2, 6, 7).

View larger version (31K):
[in a new window]
Fig. 1.
Effects of the enforced production of
glutamate racemase on the plasmid copy number in E. coli
cells. A, the plasmid copy numbers of each
E. coli JM109 clone harboring pKK223-3 (empty vector), pGR2
(vector carrying the murI gene from E. coli), or
pGR3 (vector for enforced expression of the murI gene (5)).
B, the plasmid copy numbers of each E. coli WM335
clone harboring pKK223-3, pGR2, or pGR3. These E. coli
clones were cultivated at 37 °C in 10 ml of the
D-glutamate-LB broth (2) containing Amp (50 µg/ml) and
IPTG (1 mM) until the turbidity at 600 nm of the culture
broth reached 2.1. The whole DNA was isolated by the method of Saito
and Miura (21), and the plasmid DNA was prepared by the alkali-SDS
method (12). The plasmid copy number was defined to be 1 when 1 ng of
the plasmid DNA was contained in 1 µg of the whole DNA on the basis
of the difference in molecular sizes between the plasmid DNA used and
the chromosomal DNA of E. coli. Data are representative as
means ± S.E. of eight independent experiments.
Competency of E. coli WM335 mutant defective in the glutamate
racemase gene
1); JM109/pGR2,
34 ± 12; JM109/pGR3, 39 ± 14; WM335/pKK223-3, 28 ± 13; WM335/pGR2, 30 ± 5; WM335/pGR3, 33 ± 6. It was thus
suggested that MurI affects the intracellular activity of GyrAB in
E. coli.

View larger version (31K):
[in a new window]
Fig. 2.
Effects of the enforced production of
glutamate racemase on the DNA supercoiling activity in E. coli cells. A, the DNA supercoiling activity
of each E. coli JM109 clone harboring pKK223-3, pGR2, or
pGR3. B, the DNA supercoiling activity of each E. coli WM335 clone harboring pKK223-3, pGR2, or pGR3. These E. coli clones were cultivated at 37 °C in 100 ml of the
D-glutamate-LB broth containing Amp (50 µg/ml) and IPTG
(1 mM) until the turbidity at 600 nm of the culture broth
reached 2.1. Cell extracts (0.5 ml) were prepared by the use of
lysozyme (0.3%), Brij-52 (1%), and streptomycin (2%) and dialyzed
against TED buffer (pH 7.5) containing 1% glycerol (9). The dialyzed
sample (10 µg of protein) was added to the DNA gyrase assay mixture
(see "Experimental Procedures"). Data are representative as
means ± S.E. of four independent experiments.

View larger version (17K):
[in a new window]
Fig. 3.
Dose-dependent inhibition of DNA
gyrase by glutamate racemase. A, titration of DNA
gyrase with glutamate racemase. E. coli GyrAB (20 nM) was incubated at 37 °C for 10 min in the DNA gyrase
assay mixture (20 µl) containing various concentrations (0-50
nM) of E. coli MurI (open circles),
E. coli MurI plus UDP-MurNAc-L-Ala (10 µM) (closed circles), E. coli MurI
plus D-glutamate (50 mM) (open
triangles), E. coli MurI plus L-glutamate
(50 mM) (open squares), or bovine serum albumin
plus UDP-MurNAc-L-Ala (open diamonds).
B, determination of the Ki(app)
value of glutamate racemase against DNA gyrase. A low concentration of
E. coli GyrAB (0.5 nM) was incubated at 37 °C
for 2 h with various concentrations (0-125 nM) of
E. coli MurI and UDP-MurNAc-L-Ala in the same
assay mixture as A. During the DNA gyrase reaction, both the
supercoiled DNA products thus formed and the relaxed DNA substrate thus
exhausted were determined densitometrically (see "Experimental
Procedures").
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
| |
FOOTNOTES |
|---|
* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ To whom correspondence should be addressed. Tel.: 81-88-864-5215; Fax: 81-88-864-5200; E-mail: ashiuchi@cc.kochi-u.ac.jp.
Published, JBC Papers in Press, September 3, 2002, DOI 10.1074/jbc.C200253200
2 M. Ashiuchi, E. Kuwana, K. Komatsu, K. Soda, and H. Misono, manuscript in preparation.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
UDP-MurNAc-L-Ala, UDP-N-acetylmuramyl-L-alanine;
FPLC, fast
protein liquid chromatography;
PLP, pyridoxal 5'-phosphate;
IPTG, isopropyl-1-thio-
-D-galactopyranoside.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Ashiuchi, M.,
Yoshimura, T.,
Kitamura, T.,
Kawata, Y.,
Nagai, J.,
Gorlatov, S.,
Esaki, N.,
and Soda, K.
(1995)
J. Biochem. (Tokyo)
117,
495-498 |
| 2. |
Doublet, P.,
van Heijenoort, J.,
and Mengin-Lecreulx, D.
(1992)
J. Bacteriol.
174,
5772-5779 |
| 3. |
Ashiuchi, M.,
Tani, K.,
Soda, K.,
and Misono, H.
(1998)
J. Biochem. (Tokyo)
123,
1156-1163 |
| 4. | Doublet, P., van Heijenoort, J., and Mengin-Lecreulx, D. (1996) Microb. Drug Resist. 2, 43-49[Medline] [Order article via Infotrieve] |
| 5. |
Yoshimura, T.,
Ashiuchi, M.,
Esaki, N.,
Kobatake, C.,
Choi, S.-Y.,
and Soda, K.
(1993)
J. Biol. Chem.
268,
24242-24246 |
| 6. | Ashiuchi, M., Soda, K., and Misono, H. (1999) Biosci. Biotechnol. Biochem. 63, 792-798 |
| 7. |
Balikó, G.,
and Venetianer, P.
(1993)
J. Bacteriol.
175,
6571-6577 |
| 8. |
Ferro, A. M.,
and Olivera, B. M.
(1984)
J. Biol. Chem.
259,
547-554 |
| 9. |
Nakanishi, A.,
Oshida, T.,
Matsushita, T.,
Imajoh-Ohmi, S.,
and Ohnuki, T.
(1998)
J. Biol. Chem.
273,
1933-1938 |
| 10. |
Mizuuchi, K.,
Mizuuchi, M.,
O'Dea, M. H.,
and Gellert, M.
(1984)
J. Biol. Chem.
259,
9199-9201 |
| 11. |
Kato, J.,
Suzuki, H.,
and Ikeda, H.
(1992)
J. Biol. Chem.
267,
25676-25684 |
| 12. | Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , 2nd Ed , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY |
| 13. |
Chung, C. T.,
Niemela, S. L.,
and Miller, R. H
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
2172-2175 |
| 14. | Projan, S. J., Carleton, S., and Novick, R. P. (1983) Plasmid 9, 183-190 |
| 15. |
Bhaduri, T.,
Bagui, T. K.,
Sikder, D.,
and Nagaraja, V.
(1998)
J. Biol. Chem.
273,
13925-13932 |
| 16. |
Inoue, N.,
and Uchida, H.
(1991)
J. Bacteriol.
173,
1208-1214 |
| 17. | Chandlar, M. S., and Smith, R. A. (1996) Gene (Amst.) 169, 25-31[CrossRef][Medline] [Order article via Infotrieve] |
| 18. | Snoep, J. L., van der Weijden, C. C., Andersen, H. W., Westerhoff, H. V., and Jensen, P. R. (2002) Eur. J. Biochem. 269, 1662-1669[Medline] [Order article via Infotrieve] |
| 19. | Strausberg, R. (2000) The Human Tumor Gene Index for Cancer Genome Anatomy Project (CGAP) at National Cancer Institute (www.ncbi.nlm. nih. gov/ncicgap) |
| 20. | Reina-San-Martin, B., Degrave, W., Rougeot, C., Cosson, A., Chamond, N., Cordeiro-Da-Silva, A., Arala-Chaves, M., Coutinho, A., and Minoprio, P. (2000) Nat. Med. 6, 890-897[CrossRef][Medline] [Order article via Infotrieve] |
| 21. | Saito, M., and Miura, K. (1963) Biochim. Biophys. Acta 72, 619-629[Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
S. Sengupta and V. Nagaraja YacG from Escherichia coli is a specific endogenous inhibitor of DNA gyrase Nucleic Acids Res., August 1, 2008; 36(13): 4310 - 4316. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sengupta, M. Shah, and V. Nagaraja Glutamate racemase from Mycobacterium tuberculosis inhibits DNA gyrase by affecting its DNA-binding Nucleic Acids Res., November 14, 2006; 34(19): 5567 - 5576. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Fournier and A. Klier Protein A gene expression is regulated by DNA supercoiling which is modified by the ArlS-ArlR two-component system of Staphylococcus aureus Microbiology, November 1, 2004; 150(11): 3807 - 3819. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |